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Cdc25, the dual-specificity phosphatase that dephosphorylates the Cdc2–cyclin B com-
plex at mitosis, is highly regulated during the cell cycle. In Xenopus egg extracts, Cdc25
is associated with two isoforms of the 14-3-3 protein. Cdc25 is complexed primarily with
14-3-3e and to a lesser extent with 14-3-3z. The association of these 14-3-3 proteins with
Cdc25 varies dramatically during the cell cycle: binding is high during interphase but
virtually absent at mitosis. Interaction with 14-3-3 is mediated by phosphorylation of
Xenopus Cdc25 at Ser-287, which resides in a consensus 14-3-3 binding site. Recombinant
Cdc25 with a point mutation at this residue (Cdc25-S287A) is incapable of binding to
14-3-3. Addition of the Cdc25-S287A mutant to Xenopus egg extracts accelerates mitosis
and overrides checkpoint-mediated arrests of mitotic entry due to the presence of
unreplicated and damaged DNA. These findings indicate that 14-3-3 proteins act as
negative regulators of Cdc25 in controlling the G2–M transition.
INTRODUCTION
In cycling eukaryotic cells, the entry into mitosis (M-
phase) is orchestrated by a cyclin-dependent kinase
consisting of the catalytic subunit Cdc2 and a B-type
cyclin partner. The Cdc2–cyclin B complex, also
known as MPF (maturation or M-phase promoting
factor), acts by phosphorylating a myriad of mitotic
substrates (Coleman and Dunphy, 1994; King et al.,
1994; Morgan, 1995). After MPF-catalyzed phosphor-
ylation, these substrates directly or indirectly partici-
pate in mitotic processes such as nuclear envelope
breakdown (NEB), chromosome condensation, and
spindle assembly. The proper execution of mitotic
events ultimately results in the faithful segregation of
replicated chromosomes to daughter cells.
It is essential that MPF be active for only a brief
period during the cell cycle (Elledge, 1996). For this
reason, there are elaborate posttranslational mecha-
nisms regulating both the activation of MPF at the
G2–M boundary and its subsequent inactivation at
the metaphase–anaphase transition. In the case of
the G2–M transition, the phosphorylation of Cdc2
plays an important role in proper mitotic timing
(Morgan, 1995). Cdc2 absolutely requires phosphor-
ylation on Thr-161 for catalytic activity. However,
the Thr-161-phosphorylated Cdc2– cyclin B complex
is kept inactive throughout interphase by domi-
nantly inhibitory phosphorylations on the Tyr-15
and Thr-14 residues of Cdc2. These phosphoryla-
tions are carried out collectively by the inhibitory
kinases Wee1 and Myt1 (Featherstone and Russell,
1991; Igarashi et al., 1991; Parker and Piwnica-
Worms, 1992; Mueller et al., 1995a,b). When the
conditions are appropriate for mitosis, a dual-spec-
ificity phosphatase called Cdc25 activates Cdc2– cy-
clin B by removing these inhibitory phosphates
(Dunphy and Kumagai, 1991; Gautier et al., 1991;
Strausfeld et al., 1991).
Cdc25, Wee1, and Myt1 are all highly regulated
during the cell cycle. For example, Cdc25 is virtually
inactive during interphase but undergoes a strong
activation at mitosis due to phosphorylation of its
N-terminal regulatory domain (Izumi et al., 1992;
Kumagai and Dunphy, 1992). This stimulatory phos-
phorylation process is carried out by at least two
kinases, including Cdc2–cyclin B itself and a Xenopus
homologue of the kinase Polo called Plx1 (Hoffmann et
al., 1993; Izumi and Maller, 1995; Kumagai and Dun-
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phy, 1996). In parallel with the activation of Cdc25 at
mitosis, Wee1 and Myt1 are shut-off at mitosis by
multiple regulatory kinases, one of which may be
Cdc2–cyclin B (McGowan and Russell, 1995; Mueller
et al., 1995a; Watanabe et al., 1995).
The events leading to the activation of Cdc25 and
inactivation of Wee1/Myt1 at mitosis are fundamental
problems in cell cycle control. Recently, 14-3-3 pro-
teins have been implicated in mitotic regulation (al-
Khodairy and Carr, 1992; Ford et al., 1994; Aitken,
1996; Elledge, 1996). In the fission yeast Schizosaccha-
romyces pombe, mutations in the Rad24 and Rad25
proteins, both of which are 14-3-3 homologues, dis-
rupt mitotic timing and the checkpoint response to
damaged DNA (Ford et al., 1994). In humans, two-
hybrid analysis has revealed that 14-3-3 proteins asso-
ciate with certain forms of the Cdc25 protein (Conklin
et al., 1995). In recent studies, 14-3-3 proteins have
been shown to bind to a phosphorylated serine (Ser-
216) of human Cdc25C and thereby negatively regu-
late its function (Peng et al., 1997; Sanchez et al., 1997).
In this report, we have explored the regulation of
Cdc25C (hereafter referred to simply as Cdc25) in
Xenopus egg extracts. In particular, we have focused
on the inactive form of Cdc25 found during inter-
phase. We have identified two 14-3-3 proteins that
bind to the inactive but not the active form of Cdc25.
The properties of this interaction strongly suggest that
these 14-3-3 proteins serve to suppress the activation
of Cdc25 throughout interphase in Xenopus egg ex-
tracts.
MATERIALS AND METHODS
Isolation of Cdc25-binding Proteins
Nickel-agarose beads containing His6-Cdc25 were incubated for 30
min in interphase Xenopus egg extracts or in cytostatic factor-ar-
rested (M-phase) extracts. The beads were isolated by centrifugation
(Kumagai and Dunphy, 1997) and washed once in buffer A (10 mM
HEPES-KOH [pH 7.5], 20 mM b-glycerolphosphate, 500 mM NaCl,
5 mM 2-mercaptoethanol, 5 mM ethylene glycol-bis(b-aminoethyl
ether)-N,N,N9,N9-tetraacetic acid, 0.1% 3-[(3-cholamidopropyl)-
dimethylammonio]-1-propanesulfonate, 0.1 mM sodium orthovana-
date, 10 mM phosphoserine, 10 mM phosphothreonine, and 10 mM
phosphotyrosine) containing 1 mM microcystin, washed three times
with buffer A lacking microcystin, and washed twice with HBS (10
mM HEPES-KOH [pH 7.5] and 150 mM NaCl). Bound proteins were
eluted with 150 mM imidazole in HBS, separated by SDS-PAGE,
and silver-stained.
Peptide Sequencing
The eluted 28-kDa and 31-kDa Cdc25-binding proteins were alky-
lated with iodoacetamide, separated by SDS-PAGE, and stained
with Coomassie blue. Gel pieces containing p28 and p31 were
washed with 50% acetonitrile, dried in a SpeedVac, and digested
with lysyl endopeptidase (Wako Bioproducts, Richmond, VA) or
with trypsin (Boehringer Mannheim, Indianapolis, IN), respectively
(Hellman et al., 1995). The peptides were eluted and separated by
reverse-phase chromatography. Peptide sequence analysis was per-
formed with an ABI 476A sequencer in the Caltech Protein/Peptide
Micro Analytical Laboratory.
Cloning of Xenopus 14-3-3e and 14-3-3z
14-3-3e. Two oligonucleotides (GTIGCIGGIATGGATGTIGA and
GCIGCIGGIATIAIITGTTTITC) were designed on the basis of the
peptide sequences. A polymerase chain reaction (PCR) was per-
formed with these oligonucleotides by using Xenopus oocyte cDNA
as the template (Kumagai and Dunphy, 1996). The reaction yielded
a single 250-bp fragment. A Xenopus oocyte cDNA library was
screened with the 250-bp fragment as a probe. 59 truncated and 39
truncated overlapping clones were isolated. PCR primers (a, GGA-
ATTCCATATGGAAGAGCGAGAGGATTTAG; b, GGAATTCCC-
CAGTCAGATATCCAGTAGTAC) were designed for the 59 and 39
ends of the open reading frame. A PCR was performed with oligo-
nucleotides a and b by using Xenopus oocyte cDNA to obtain the
complete coding sequence flanked by NdeI and EcoRI sites. The PCR
product was cloned into the pET9His6 vector that had been di-
gested with NdeI and EcoRI. The insert was sequenced by standard
methods.
14-3-3z. Two oligonucleotides containing an NdeI site at the start
codon and an EcoRI site after the stop codon were designed by using
the published Xenopus 14-3-3z sequence (GenBank accession num-
ber X95519; Kousteni et al., 1997). These primers (c, GGAATTCCA-
TATGGATAAAAATGAACTGGTCCAG; d, GGAATTCCTTAGTT-
CTCCCCTCCTTCTCCTTG) were used to amplify a fragment from
Xenopus oocyte cDNA, which was then cloned into pET9His6 vec-
tor. The insert was sequenced by standard methods. The sequence
matched the published sequence of the Xenopus 14-3-3z protein
except for a small stretch from amino acids 172 to 187. Because this
region is highly conserved among 14-3-3 proteins, the previously
published sequence is most likely erroneous in this area.
Production of Antibodies to His6-14-3-3e and His6-
14-3-3z
Escherichia coli BL21DE3(LysS) was transformed with either
pET9His6-14-3-3e or pET9His6-14-3-3z. Proteins were expressed by
adding 0.4 mM isopropyl b-d-thiogalactoside at 20°C for 3 h. Cells
were harvested and stored frozen at 280°C. Cells were suspended
in 0.2 M Tris(hydroxymethyl)aminomethane hydrochloride (Tris-
HCl, pH 7.5), 0.5 M NaCl, 0.1% Triton X-100, 5 mM 2-mercaptoetha-
nol, 1 mM phenylmethylsulfonyl fluoride, 10 mg/ml pepstatin, 10
mg/ml chymostatin, and 10 mg/ml leupeptin and sonicated. The
lysate was centrifuged at 10,000 rpm for 10 min in an HB-4 rotor
(DuPont, Newtown, CT). The supernatant was mixed with nickel-
agarose beads for 30 min at 4°C. Bound proteins were washed three
times with 0.2 M Tris-HCl (pH 7.5), 0.5 M NaCl, 0.1% Triton X-100,
and 5 mM 2-mercaptoethanol and three times with HBS. The His6-
14-3-3 proteins were eluted with 150 mM imidazole in HBS. Rabbit
polyclonal antibodies were raised at a commercial facility. Antibod-
ies were affinity-purified by using His6-14-3-3 protein that had been
coupled to CNBr-activated Sepharose (Pharmacia, Piscataway, NJ).
The anti-14-3-3e antibodies used in this article could immunopre-
cipitate both 14-3-3e and 14-3-3z but could detect only 14-3-3e in
immunoblots. The anti-14-3-3z antibodies did not cross-react with
14-3-3e in immunoblots and could not immunoprecipitate 14-3-3e.
Production of Wild-Type and S287A His6-Cdc25
Proteins in Insect Cells
The NcoI–XhoI fragment of Xenopus Cdc25 was produced by PCR
using Pfu DNA polymerase (Stratagene, La Jolla, CA), pBluescript
SK-Cdc25-1 (Kumagai and Dunphy, 1992) as the template, and the
following two oligonucleotides: Cdc25-NcoI, CATGCCATGGCAG-
AGAGTCACATAATG; Cdc25-XhoI, TTCGGCTCGAGTTAAAGC-
TTCATTATGCGGGC. The fragment was digested with NcoI and
XhoI and cloned into pFastBacHTa. The His6-Cdc25-S287A mutant
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was created by PCR using two oligonucleotides (CTAGTCTAGA-
GCGGTTTAAAGATATATTGTTTACATTG and CTAGTCTAGAC-
TTTACCGATCGCCTGCTATGCC) in addition to the two oligonu-
cleotides described above. The resulting two PCR fragments were
digested with either NcoI and XbaI or XbaI and XhoI and then cloned
into pFastBacHTa that had been digested with NcoI and XhoI. Bacu-
loviruses were produced by using the Bac-to-Bac baculovirus ex-
pression system (Life Technologies, Gaithersburg, MD). Proteins
were harvested from Sf9 insect cells after 48 h of infection and
purified by using nickel-agarose beads (Pharmacia) as described
(Kumagai and Dunphy, 1997).
Phosphopeptide Mapping
Nickel-agarose beads (5 ml) containing either wild-type His6-Cdc25
or His6-Cdc25-S287A were incubated for 50 min in 100 ml of Xeno-
pus interphase egg extract containing 100 mg/ml cycloheximide and
0.1 mCi of [32P]orthophosphate. Beads were washed once with
buffer A containing 1 mM microcystin, three times with buffer A,
and twice with HBS. Proteins were eluted with 150 mM imidazole
in HBS. Samples were boiled in SDS sample buffer containing 15
mM dithiothreitol for 2 min. After cooling the sample to room
temperature, 50 mM iodoacetamide was added and samples were
incubated at room temperature for 15 min in the dark. Samples were
separated by SDS-PAGE, and radioactive bands corresponding to
the His6-Cdc25 protein were excised. The gel pieces were swollen in
25 mM ammonium bicarbonate and then washed in 50% acetoni-
trile/25 mM ammonium bicarbonate for three 30-min periods under
agitation. The gel piece was dried in a SpeedVac. Trypsin (1 mg)
dissolved in 25 mM ammonium bicarbonate was added to the dried
gel piece. After swelling, additional 25 mM ammonium bicarbonate
was added to immerse the gel piece. After an overnight incubation
at 37°C, the supernatant was collected, and the gel piece was incu-
bated once in 25 mM ammonium bicarbonate and twice in 50%
acetonitrile/0.1% trifluoroacetic acid to elute digested peptides. The
eluted peptides were pooled, dried in a SpeedVac, and subjected to
thin layer electrophoresis and chromatography as described (Boyle
et al., 1991).
Preparation of Xenopus Egg Extracts
Xenopus egg extracts were prepared as described previously (Mur-
ray, 1991; Mueller et al., 1995a). To impose the replication check-
point, interphase egg extracts containing 1000 demembranated
sperm nuclei per microliter were treated with 100 mg/ml aphidico-
lin (Dasso and Newport, 1990). Demembranated sperm nuclei were
prepared from Xenopus testis as described (Smythe and Newport,
1991). To prepare UV-damaged nuclei, sperm nuclei were spread on
Parafilm at a concentration of 105 nuclei per ml and treated with UV
light (254 nm) in a Stratalinker (Stratagene) at a dose of 888 J/m2.
Endogenous Cdc25 was immunodepleted from Xenopus egg extracts
with anti-Cdc25 antibodies and Affi-prep protein A beads (Bio-Rad,
Richmond, CA) that had been incubated in 1 mg/ml bovine serum
albumin as described (Carpenter et al., 1996; Coleman et al., 1996).
Cdc25 was immunodepleted from M-phase extracts prior to activa-
tion with calcium ion to avoid removal of endogenous 14-3-3 pro-
teins.
Assay of the Activity of the Cdc25 Protein
A 32P-labeled Cdc2–cyclin B1 complex was prepared by phosphor-
ylating Cdc2 with Myt1 as described (Kumagai and Dunphy, 1997).
Nickel-agarose beads containing either His6-Cdc25 or His6-Cdc25-
S287A were mixed with interphase extracts containing 100 mg/ml
cycloheximide for 30 min at room temperature to allow the phos-
phorylation of Ser-287 and subsequent binding of Xenopus 14-3-3
proteins. Beads were washed as described above. The 32P-phosphor-
ylated Cdc2–cyclin B1 complex was mixed with His6-Cdc25 protein
or His6-Cdc25-S287A protein in the presence of 50 mg/ml His6-14-
3-3e protein in phosphatase buffer containing 5 mM dithiothreitol
(Kumagai and Dunphy, 1997). Aliquots were taken at various times
and the reaction was stopped by the addition of the gel sample
buffer. Samples were separated by SDS-PAGE and the 32P remain-
ing in Cdc2 was quantitated with a PhosphorImager.
RESULTS
Xenopus Cdc25 Associates with Two 14-3-3 Proteins
To explore the mechanisms underlying the activation
of Cdc25 at mitosis, we asked whether potential reg-
ulatory proteins would associate with Cdc25 in Xeno-
pus egg extracts during the course of the cell cycle. For
this purpose, we first added nickel-agarose beads con-
taining a histidine-tagged version of Cdc25 (His6-
Cdc25) to interphase or M-phase egg extracts. After a
30-min incubation at 23°C, we reisolated the nickel
agarose beads. Subsequently, the beads were washed
extensively and bound proteins were eluted with im-
idazole. Gel electrophoresis and silver staining re-
vealed the presence of two proteins with molecular
masses of 28 kDa and 31 kDa (p28 and p31) that
appeared to associate with the interphase form of
His6-Cdc25 (Figure 1, lane 1). In control experiments,
there was no binding of these two proteins to nickel-
agarose lacking His6-Cdc25, indicating that these pro-
teins do not bind nonspecifically to the nickel resin.
Interestingly, the 28- and 31-kDa proteins did not
associate with the M-phase hyperphosphorylated ver-
sion of His6-Cdc25 (Figure 1, lane 2), suggesting that
the interaction of these proteins with Cdc25 might
vary during the cell cycle.
Next, we excised gel pieces containing the 28- and
31-kDa proteins and extensively digested both pro-
teins in situ with lysyl endopeptidase or trypsin. Se-
quencing of three peptides from p28 revealed that it is
a previously cloned Xenopus 14-3-3 protein (Kousteni
Figure 1. The 28-kDa and 31-kDa proteins bind to the interphase
form of Xenopus Cdc25. Nickel-agarose beads containing His6-
Cdc25 protein were incubated in interphase (lane 1) or M-phase
(lane 2) egg extracts. Bound proteins were eluted with 150 mM
imidazole in HBS, separated by SDS-PAGE, and silver stained.
From the 31-kDa protein, we obtained the following peptide se-
quences: 1, VAGMDVELTVEER; 2, SIXNDILDVLDKHLIPAASS-
GESK. From the 28-kDa protein, we obtained the following three
sequences: 3, RVTEEGGELSNEERNLLSVAYK; 4, GDYYRYLAE-
VAAGNAK; 5, AAFDEAIAELDTLSEESYK. X denotes unreadable
residues.
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et al., 1997). More specifically, p28 appears to corre-
spond to the z isoform of Xenopus 14-3-3. Peptide
sequencing suggested that p31 is also a 14-3-3 protein,
but this particular isoform had not been identified
previously from Xenopus. Therefore, we set out to
clone the cDNA encoding this protein from a Xenopus
oocyte library. With oligonucleotides based on the
peptide sequences, we were able to amplify a single
250-bp fragment in a PCR. After obtaining and se-
quencing a full-length clone, we established that p31
corresponds to the e isoform of Xenopus 14-3-3 (Figure
2), because it is 97% identical to human 14-3-3e (Con-
klin et al., 1995). Among vertebrate 14-3-3 proteins, the
e isoform bears the greatest similarity to the Rad24
and Rad25 gene products of S. pombe (Ford et al., 1994).
To examine the functional properties of p28 (14-3-3z)
and p31 (14-3-3e) in Xenopus egg extracts, we prepared
histidine-tagged versions of both proteins (Figure 3)
and then raised polyclonal antibodies in rabbits
against each polypeptide. By immunoblotting, the an-
ti-14-3-3e antibodies recognize a single band of the
anticipated size (Figure 3). The anti-14-3-3z antibodies
detect a doublet of proteins in egg extracts, with the
lower band matching the expected size of 14-3-3z (Fig-
ure 3). In principle, the upper band of the doublet
could represent a modified form of 14-3-3z or a dis-
tinct isoform of 14-3-3 with which the anti-14-3-3z
antibodies cross-react in immunoblots. We also used
the anti-14-3-3 antibodies to measure the endogenous
concentrations of 14-3-3e and 14-3-3z in Xenopus ex-
tracts. With known amounts of recombinant His6-14-
3-3e and His6-14-3-3z as standards, we established
that 14-3-3e and 14-3-3z are each present at a concen-
tration of approximately 40 mg/ml in egg extracts.
This value corresponds to a molar concentration of 1.3
mM and 1.4 mM for the 14-3-3e and 14-3-3z polypep-
tides, respectively. Because 14-3-3 proteins are known
to form dimers (Aitken, 1996), the effective concentra-
tion of homodimeric 14-3-3e and 14-3-3z would be 0.65
mM and 0.7 mM. By comparison, the concentration of
endogenous Xenopus Cdc25C in such extracts is ap-
proximately 10 mg/ml or 0.14 mM (Kumagai and Dun-
phy, 1992).
Figure 2. Comparison of the amino acid sequences of the Xenopus 14-3-3e and 14-3-3z proteins. Peptides from the amino acid sequencing
analysis in Figure 1 are underlined. The GenBank accession numbers for the DNA sequences of Xenopus 14-3-3e and 14-3-3z are AF033311
and AF033312, respectively.
Figure 3. The proteins 14-3-3e and 14-3-3z are abundant in Xenopus
egg extracts. Bacterially expressed His6-14-3-3e (lane 1, 2.5 mg of
protein; lane 3, 40 ng of protein), His6-14-3-3z (lane 2, 2.5 mg of
protein; lane 5, 40 ng of protein), and 1 ml of interphase egg extract
(lanes 4 and 6) were subjected to SDS-PAGE and either stained with
Coomassie blue (lanes 1 and 2) or immunoblotted with anti-14-3-3e
antibodies (lanes 3 and 4) or anti-14-3-3z antibodies (lanes 5 and 6).
Note that the electrophoretic mobilities of the recombinant 14-3-3
proteins are reduced due to the presence of a six-histidine tag.
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14-3-3 Proteins Bind to Ser-287 of Xenopus Cdc25
14-3-3 proteins have been shown to bind to a phos-
phoserine-containing motif. For example, 14-3-3 asso-
ciates with the sequence RSTSTP in the protein kinase
Raf, in which the underlined serine is phosphorylated
(Muslin et al., 1996). Human Cdc25C contains a similar
sequence (RSPS216MP), and it has been established
that phosphorylation of Ser-216 is required for the
interaction of 14-3-3 with human Cdc25C (Ogg et al.,
1994; Peng et al., 1997).
Xenopus Cdc25 contains an identical sequence
(RSPS287MP) at a similar location within the polypep-
tide. To evaluate whether Xenopus Cdc25 is phosphor-
ylated on Ser-287 in egg extracts, we changed this
residue to Ala by site-directed mutagenesis to gener-
ate the His6-Cdc25-S287A mutant. Next, we added
either wild-type His6-Cdc25 or the mutant His6-
Cdc25-S287A to interphase extracts that had been
equilibrated with [32P]orthophosphate to radiolabel
endogenous ATP. Subsequently, the radiolabeled
wild-type and S287A forms of His6-Cdc25 were sub-
jected to tryptic phosphopeptide analysis. We ob-
served that the map of the S287A mutant was missing
a single major tryptic phosphopeptide (Figure 4),
which suggests strongly that Ser-287 is a physiological
site of phosphorylation in the Xenopus system.
To ask whether phosphorylation at Ser-287 mediates
the interaction of 14-3-3 with Xenopus Cdc25, we
added the wild-type and S287A forms of His6-Cdc25
to both interphase and M-phase egg extracts. Subse-
quently, we recovered the wild-type and mutant pro-
teins with nickel-agarose and examined their associa-
tion with 14-3-3 by immunoblotting with anti-14-3-3
antibodies. In particular, immunoblotting with anti-
14-3-3e antibodies indicated that 14-3-3e binds to the
interphase form of wild-type His6-Cdc25 but not the
S287A mutant (Figure 4). By this analysis, neither the
wild-type nor mutant Cdc25 could be found in a com-
plex with 14-3-3e during M-phase. In parallel studies,
we demonstrated by immunoblotting with the anti-14-
3-3z antibodies that Xenopus 14-3-3z also binds to the
interphase but not M-phase form of wild-type His6-
Cdc25, whereas it cannot associate with the His6-
Cdc25-S287A mutant at either interphase or M-phase
(our unpublished data). Collectively, these experi-
ments establish that phosphorylation at Ser-287 is re-
quired for the binding of the e and z forms of 14-3-3 to
Xenopus Cdc25.
Endogenous Cdc25 in Xenopus Egg Extracts Is
Associated Quantitatively with 14-3-3
To characterize the interaction between Cdc25 and
14-3-3 in greater detail, we used the anti-14-3-3 anti-
bodies to immunoprecipitate endogenous Cdc25 from
Xenopus egg extracts. In addition to verifying that
14-3-3e and -z bind to endogenous Cdc25 in egg ex-
tracts, these studies allowed us to examine the stoichi-
ometry and regulation of this association. Immuno-
precipitation with anti-14-3-3e and -z antibodies
revealed that endogenous Cdc25 in interphase extracts
is associated mainly with the e form of 14-3-3 (Figure
Figure 4. Phosphorylation of
Ser-287 in Xenopus Cdc25 is essen-
tial for the binding of 14-3-3 pro-
teins. (A and B) Tryptic phos-
phopeptide mapping of His6-
Cdc25 (A) and His6-Cdc25-S287A
(B) that had been radiolabeled in
interphase extracts. Arrows indi-
cate the expected position of the
phosphopeptide containing Ser-
287. Origins are indicated by a dot
in the lower left of each map. (C)
The His6-Cdc25-S287A mutant
does not bind to 14-3-3e in egg
extracts. His6-Cdc25 (lanes 1 and
2) and His6-Cdc25-S287A (lanes 3
and 4) were incubated in either
M-phase (lanes 1 and 3) or inter-
phase (lanes 2 and 4) extracts. The
proteins were reisolated as de-
scribed in MATERIALS AND
METHODS and subjected to SDS-
PAGE and immunoblotting with
anti-Cdc25 antibodies (top) or an-
ti-14-3-3e antibodies (bottom).
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5). By quantitating the amount of Cdc25 that could be
immunoprecipitated with the anti-14-3-3 antibodies,
we estimate that 86% of the Cdc25 is associated with
14-3-3e; most or all of the remaining Cdc25 appears to
be bound to 14-3-3z. These findings suggest that en-
dogenous Cdc25 has a higher affinity for 14-3-3e than
for 14-3-3z. Our observation that both 14-3-3e and
14-3-3z bind with nearly equal efficiency to recombi-
nant His6-Cdc25 (see Figure 1) may be due to the fact
that this protein was added to the extract at a concen-
tration that is higher than that of the endogenous
Cdc25 (1 mM versus 0.14 mM). Consistent with the
results described above, neither the anti-14-3-3e nor
the anti-14-3-3z antibodies could immunoprecipitate
the M-phase form of endogenous Cdc25 (Figure 5).
In fission yeast and humans, 14-3-3 proteins have
been implicated in the G2–M checkpoint (Ford et al.,
1994; Peng et al., 1997; Sanchez et al., 1997). In the
Xenopus system, a putative DNA damage checkpoint
response can be elicited by the addition of UV-treated
sperm chromatin (Kumagai and Dunphy, unpub-
lished data). The replication checkpoint can be trig-
gered by the addition of the DNA polymerase inhib-
itor aphidicolin and sperm chromatin (Dasso and
Newport, 1990).
To examine the effect of damaged DNA on the in-
teraction between 14-3-3 and Cdc25, we immunopre-
cipitated Xenopus egg extracts containing UV-dam-
aged nuclei with antibodies against the e and z forms
of 14-3-3. These experiments indicated that the bind-
ing of both 14-3-3 proteins to Cdc25 is similar in the
absence and presence of damaged DNA (Figure 5). In
other experiments, we observed that the association of
both 14-3-3 proteins with Cdc25 is essentially identical
in aphidicolin-treated extracts containing unreplicated
DNA and in control extracts lacking this replication
inhibitor (Yakowec and Dunphy, unpublished data).
Collectively, these experiments indicate that the inac-
tive form of Cdc25 found during interphase is quan-
titatively associated with 14-3-3 proteins. Further-
more, this interaction is maintained in the presence of
damaged and unreplicated DNA.
Effect of the S287A Mutant of Cdc25 on Cell Cycle
Progression in Xenopus Egg Extracts
The above studies indicate that the inactive form of
Cdc25 in interphase extracts is associated with 14-3-3
proteins, whereas the mitotically active version of
Cdc25 is devoid of 14-3-3 proteins. To explore the
possibility that 14-3-3 proteins play a causal role in
suppressing Cdc25 during interphase, we asked
whether the S287A version of Cdc25 with a mutation
in its 14-3-3 binding site would affect the transit
through the cell cycle in Xenopus egg extracts (Figure
6). For this purpose, we introduced either the wild-
type or S287A form of His6-Cdc25 into various types
of Xenopus egg extracts and then examined the effect
on mitotic timing, as observed by the breakdown of
reconstituted nuclei in the extracts. Because the fission
yeast 14-3-3 homologues Rad24 and Rad25 had been
implicated in G2 checkpoint control (Ford et al., 1994),
we examined the effect of the S287A mutant on egg
extracts containing unreplicated or damaged DNA. In
one set of experiments, we treated extracts containing
sperm chromatin (1000 nuclear equivalents of DNA
per ml of extract) with aphidicolin to impose the rep-
lication checkpoint. Subsequently, we added wild-
type His6-Cdc25, the His6-Cdc25-S287A mutant, or
control buffer to the extracts and then monitored the
timing of NEB. Typically, we introduced the recombi-
nant His6-Cdc25 proteins to a final concentration of 10
mg/ml (0.14 mM). Because the concentration of endog-
enous Cdc25 is also 10 mg/ml (0.14 mM), this proce-
dure doubles the total concentration of Cdc25 in the
extracts. As expected, the aphidicolin-treated extracts
containing added buffer alone remained in interphase
for at least 150 min (Figure 6A). For comparison, con-
trol extracts lacking unreplicated DNA entered mito-
sis 75–90 min after activation. Both the wild-type and
S287A mutant His6-Cdc25 proteins triggered mitosis
in the absence of DNA replication and thus overrode
Figure 5. Xenopus Cdc25 binds mainly to 14-3-3e in interphase
extracts. Two microliters of M-phase extract (lane 1), interphase
extract containing no sperm nuclei (lane 2), and interphase extract
containing 3000 UV-damaged sperm nuclei per ml (lane 3) were
subjected to SDS-PAGE and immunoblotted with anti-Cdc25 anti-
bodies (top), anti-14-3-3e antibodies (middle), or anti-14-3-3z anti-
bodies (bottom). One hundred microliters of M-phase extract (lanes
4, 7, and 10), interphase extract containing no sperm nuclei (lanes 5,
8, and 11), and interphase extract containing 3000 UV-damaged
sperm nuclei/ml (lanes 6, 9, and 12) were immunoprecipitated with
control antibodies (lanes 4–6), anti-14-3-3e antibodies (lanes 7–9), or
anti-14-3-3z antibodies (lanes 10–12). Immunoprecipitated proteins
were separated by SDS-PAGE and immunoblotted with anti-Cdc25
antibodies (top), anti-14-3-3e antibodies (middle), or anti-14–3-3z
antibodies (bottom). All extracts contained 100 mg/ml cyclohexi-
mide.
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the replication checkpoint. Significantly, the effect of
the S287A mutant was much more pronounced. This
mutant elicited half-maximal NEB at 90–95 min,
which is approximately 40–45 min earlier than the
time of half-maximal NEB in the extract containing
wild-type His6-Cdc25 (Figure 6A). In parallel experi-
ments, we found that exogenously added wild-type
His6-Cdc25 and His6-Cdc25-S287A proteins could
override the checkpoint-induced delay of mitosis in
the presence of UV-damaged DNA (Figure 6B). As in
the aphidicolin-treated extracts, the S287A mutant
was more effective, eliciting mitosis approximately 20
min earlier than wild-type His6-Cdc25.
In other experiments, we asked whether the His6-
Cdc25-S287A would affect mitotic timing in extracts
lacking a replication inhibitor or damaged DNA.
For these experiments, we first immunodepleted the
endogenous Cdc25 in the egg extracts with anti-
Cdc25 antibodies (Figure 6C). As expected, Cdc25-
depleted extracts were unable to enter mitosis. In
control extracts that had undergone a mock immu-
nodepletion with an irrelevant antibody (rabbit an-
ti-mouse IgG), NEB occurred at about 120 min. We
found that both wild-type His6-Cdc25 and His6-
Cdc25-S287A mutant could restore the ability of
Cdc25-depleted extracts to proceed into M-phase.
However, consistent with the results described
above, NEB was consistently 20 –30 min earlier in
extracts containing the S287A mutant. Collectively,
these experiments suggest that 14-3-3 proteins pro-
vide an inhibitory constraint on Cdc25. When this
inhibitory mechanism is abolished by destruction of
the 14-3-3 binding site in Cdc25, Xenopus egg ex-
tracts enter mitosis at an accelerated pace and are
unable to arrest effectively in interphase in response
to unreplicated and UV-damaged DNA.
Effect of 14-3-3 Proteins on Cdc25 Activity
The above experiments implicate 14-3-3 proteins as
negative regulators of Cdc25. In principle, 14-3-3
proteins could inhibit the catalytic activity of Cdc25.
Alternatively, 14-3-3 proteins could influence the
action of Cdc25 by inhibiting its interaction with
positive regulators, enhancing its recognition by
negative regulators, or by physically preventing its
contact with the Cdc2– cyclin B complex. As a first
step to distinguish between the possibilities, we
asked whether binding of 14-3-3 would affect the in
vitro phosphatase activity of Cdc25 (Figure 7). For
this purpose, we preincubated the wild-type His6-
Cdc25 and His6-Cdc25-S287A proteins in Xenopus
egg extracts. During this incubation, the wild-type
but not the mutant protein became phosphorylated
on Ser-287 and bound to 14-3-3. Next, we isolated
the wild-type and mutant Cdc25 proteins with nick-
el-agarose and incubated them with both recombi-
nant His6-14-3-3e and a Cdc2– cyclin B complex that
had been phosphorylated with 32P in vitro on both
Tyr-15 and Thr-14 by treatment with recombinant
Myt1 kinase. Dephosphorylation of the radiolabeled
Cdc2 protein was monitored by SDS gel electro-
phoresis. We observed that under these experimen-
tal conditions the phosphatase activity of the His6-
Cdc25-S287A mutant that cannot bind to 14-3-3 was
only slightly higher (less than twofold) than that of
the wild-type His6-Cdc25 containing 14-3-3.
Figure 6. Cdc25-S287A mutant induces mitosis more efficiently
than the wild-type Cdc25 protein. His6-Cdc25 (), His6-Cdc25-
S287A (F), or buffer alone (f) were added to the interphase egg
extracts containing either aphidicolin (A) or UV-damaged sperm
nuclei (B). (C) Xenopus egg extracts were immunodepleted with
anti-Cdc25 antibodies (, F, or E) or control rabbit anti-mouse IgG
antibodies (M). We verified by immunoblotting with anti-Cdc25
antibodies that Cdc25 was quantitatively removed by this proce-
dure. To the Cdc25-depleted extracts, we added His6-Cdc25 (),
His6-Cdc25-S287A (F), or buffer alone (E). Buffer alone was added
to the control-depleted extract (M). (A–C) Recombinant His6-Cdc25
and His6-Cdc25-S287A were added to a final concentration of 10
mg/ml (0.14 mM). Aliquots were taken at the indicated times and
NEB was monitored by microscopy.
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DISCUSSION
In this report, we have examined the regulation of the
mitotic inducer Cdc25C by 14-3-3 proteins during the
cell cycle in Xenopus egg extracts. We have observed
that the inactive hypophosphorylated form of Cdc25
present during interphase is quantitatively associated
with two 14-3-3 proteins (p28 and p31). p31 is most
similar to the e form of 14-3-3 and appears to be the
major partner of Cdc25: approximately 86% of Cdc25
is bound to 14-3-3e during interphase. The other bind-
ing partner (p28) most closely resembles the 14-3-3z
protein. It appears that most, if not all, of the inactive
Cdc25 in Xenopus extracts is bound to either the e or z
form of 14-3-3. Furthermore, both the e and z ho-
modimers would each be present in an approximately
fivefold molar excess over Cdc25 in egg extracts. Thus,
the abundance of 14-3-3 proteins and the stoichiome-
try of their interaction with Cdc25 could account for
the suppression of endogenous Cdc25 in Xenopus egg
extracts during interphase.
A variety of observations strongly suggest that these
14-3-3 proteins act as negative regulators of Cdc25.
First, the binding of 14-3-3 proteins to Cdc25 is highly
regulated during the cell cycle. 14-3-3 proteins bind
only to the interphase form of Cdc25 that displays
weak activity toward the Cdc2–cyclin B complex. In
contrast, the mitotic form of Cdc25 that can efficiently
dephosphorylate Cdc2–cyclin B contains no detect-
able 14-3-3 protein. Another argument that 14-3-3 pro-
teins negatively regulate Cdc25 is that a mutant of
Cdc25 containing a single amino acid change that
completely abrogates 14-3-3 binding shows a strongly
enhanced ability to induce mitosis. This Cdc25-S287A
mutant can compromise the checkpoints involving un-
replicated and damaged DNA. In the case of the rep-
lication checkpoint, Xenopus egg extracts containing
unreplicated DNA and the Cdc25-S287A mutant enter
mitosis efficiently even though DNA synthesis has
been completely abolished by the treatment with
aphidicolin. Significantly, in such extracts, mitosis
takes place at about 90 min after activation of the
extract, which corresponds to the time that extracts
lacking aphidicolin would normally enter mitosis. It
appears that the presence of the Cdc25-S287A mutant
largely abolishes the responsiveness of Xenopus egg
extracts to unreplicated/damaged DNA. Recently,
Peng et al. (1997) have shown that a mutant of human
Cdc25C (S216A) with a defective 14-3-3 binding site
overrides G2 checkpoint controls in human cells. Thus,
the regulation of Cdc25 by binding of 14-3-3 proteins
appears to be a conserved mechanism of checkpoint
control in vertebrates.
The molecular mechanism by which 14-3-3 proteins
suppress the action of Cdc25 remains to be estab-
lished. Because 14-3-3 proteins are known to form
dimers (Aitken, 1996), it is plausible that the binding
of 14-3-3 may serve to oligomerize Cdc25 in egg ex-
tracts during interphase. As described herein, the
binding of 14-3-3 appears to result in only a modest
suppression (less than twofold) of the ability of Cdc25
to dephosphorylate a recombinant Cdc2–cyclin B
complex, but we cannot be certain that these in vitro
assays faithfully recapitulate the conditions found in
vivo. Notwithstanding this caveat, it is conceivable
that such a small effect on Cdc25 activity could tip the
balance between the competing actions of Cdc25 and
Wee1/Myt1 so that the Tyr-15 and Thr-14 dephos-
phorylation of Cdc2 could not proceed as long as
14-3-3 proteins remain bound, but other possibilities
must also be considered. For example, the binding of
14-3-3 could preclude the interaction of Cdc25 with
positive regulators. At least two kinases, including
Cdc2–cyclin B and Plx1, phosphorylate Cdc25 in its
N-terminal regulatory domain and stimulate its phos-
phatase activity at mitosis (Izumi and Maller, 1995;
Kumagai and Dunphy, 1996). Perhaps binding of 14-
3-3 could hinder the ability of these kinases to carry
out their stimulatory phosphorylations. Alternatively,
14-3-3 proteins could enhance the ability of Cdc25 to
interact with negative regulators such as the PP2A-
like, Cdc25-inhibitory phosphatase (Kumagai and
Dunphy, 1992; Clarke et al., 1993).
Another type of explanation for the function of 14-
3-3 would be that these proteins might preclude the
ability of Cdc25 to interact physically with the Cdc2–
cyclin B complex. For example, 14-3-3 proteins could
Figure 7. Effect of 14-3-3 proteins on Cdc25 activity. Nickel-agar-
ose beads containing His6-Cdc25 protein and the His6-Cdc25-S287A
mutant protein were incubated in interphase extracts. Beads were
isolated and bound proteins were eluted with 150 mM imidazole in
HBS. A 32P-phosphorylated Cdc2–cyclin B complex phosphorylated
in vitro by Myt1 was mixed with His6-Cdc25 (), His6-Cdc25-
S287A (F), or control buffer (f) in the presence of 50 mg/ml His6-
14-3-3e protein. Aliquots were taken at the times indicated and
subjected to SDS-PAGE. 32P remaining on Cdc2 was quantitated by
using a PhosphorImager. In control experiments, His6-Cdc25 and
His6-Cdc25-S287A purified directly from baculovirus-infected in-
sect cells showed very similar Cdc2-specific phosphatase activity.
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directly affect the recognition of Cdc2–cyclin B by
Cdc25 or could indirectly prevent this interaction by
keeping Cdc25 at an intracellular location where it
would not have access to Cdc2–cyclin B. Xenopus
Cdc25 contains an excellent putative bipartite nuclear
localization signal with the sequence KRPVRPLDSET-
PVRVKRRR (the two basic clusters are underlined).
Intriguingly, this putative nuclear localization se-
quence resides at amino acid residues 298 to 315 in
Cdc25 and thus lies in close proximity to the 14-3-3
binding site around Ser-287, raising the possibility that
binding of 14-3-3 could influence the intracellular lo-
calization of Cdc25. The localization of Cdc25C varies
somewhat depending on the cell type. In human and
fission yeast cells, Cdc25C is a nuclear protein during
G2-phase (Millar et al., 1991; Girard et al., 1992). In
hamster cells, Cdc25C is cytoplasmic during G2 and
enters the nucleus at about the beginning of mitosis
(Seki et al., 1992). At this time, it is not known whether
the intracellular localization of Cdc25C plays a causal
role in mitotic entry.
Recent studies have implicated Chk1 as the kinase
that phosphorylates Ser-216 in the 14-3-3 binding site
of human Cdc25C (Peng et al., 1997; Sanchez et al.,
1997). A Xenopus homologue of Chk1 has not been
described, but clearly it will be valuable to ask
whether a putative Chk1 homologue can phosphory-
late Ser-287 of Xenopus Cdc25 to allow the binding of
14-3-3e and 14-3-3z. Interestingly, the binding of 14-
3-3e and -z to Xenopus Cdc25 is similar whether or not
the replication/damage checkpoint has been acti-
vated. This observation suggests that a kinase that
phosphorylates Ser-287 is active in the absence of a
checkpoint-triggered delay of mitosis. Thus, the func-
tion of Chk1 could be to maintain this critical phos-
phorylation of Cdc25 past the time at which mitosis
would normally occur in an extract lacking unrepli-
cated or damaged DNA.
In previous studies, we have analyzed the activities
of the various enzymes controlling the tyrosine phos-
phorylation of Cdc2 in the absence and presence of
unreplicated DNA (Kumagai and Dunphy, 1992, 1995;
Mueller et al., 1995a,b). These studies have indicated
that both Wee1 and Myt1 are highly active during
interphase and that their kinase activities toward
Cdc2–cyclin B as measured in vitro are not detectably
altered by the presence of unreplicated DNA. In the
case of Cdc25, its phosphatase activity is maintained
in the same inactive state in the presence and absence
of unreplicated DNA. It is apparent that this inactive
form of Cdc25 is complexed with 14-3-3 proteins and
that imposition of the replication checkpoint would
keep Cdc25 in this state. As a consequence, the de-
phosphorylation of Tyr-15 and Thr-14 on Cdc2 would
be precluded. A similar mechanism appears to ac-
count for the interphase arrest of egg extracts contain-
ing UV-damaged DNA. According to this scheme, the
inhibitory phosphorylation of Cdc2 would be the ul-
timate target of the unreplicated and damaged DNA
checkpoints in Xenopus egg extracts, as is the case in
fission yeast and humans (Enoch and Nurse, 1990;
Lundgren et al., 1991; Jin et al., 1996; Blasina et al., 1997;
Furnari et al., 1997; O’Connell et al., 1997; Peng et al.,
1997; Rhind et al., 1997; Sanchez et al., 1997).
In conclusion, we have found that 14-3-3 proteins
negatively regulate the ability of Cdc25 to induce mi-
tosis in Xenopus egg extracts. When this negative reg-
ulatory system is compromised by a mutation that
prevents Cdc25 from interacting with 14-3-3, the un-
replicated and damaged DNA checkpoints are unable
to operate properly. In the future, it will be important
to elucidate the molecular mechanisms controlling the
association of 14-3-3 proteins with Cdc25 and how
these regulatory mechanisms are modulated by un-
replicated and damaged DNA.
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